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Abstract: 
The unsaturated fatty acid, oleate exhibits anorexigenic properties reducing food intake 
and hepatic glucose output. However, its mechanism of action in the hypothalamus has 
not been fully determined. This study investigated the effects of oleate and glucose on 
GT1-7 mouse hypothalamic cells (a model of glucose-excited (GE) neurones) and mouse 
arcuate nucleus (ARC) neurones.  Whole-cell and perforated patch-clamp recordings, 
immunoblotting and cell energy status measures were used to investigate oleate and 
glucose sensing properties of mouse hypothalamic neurones.  Oleate or lowered glucose 
concentration caused hyperpolarisation and inhibition of firing of GT1-7 cells by the 
activation of ATP-sensitive K+ channels (KATP). This effect of oleate was not dependent 
on fatty acid oxidation or raised AMP-activated protein kinase activity or prevented by 
the presence of the UCP2 inhibitor genipin. Oleate did not alter intracellular calcium, 
indicating that CD36/fatty acid translocase may not play a role. However, oleate 
activation of KATP may require ATP metabolism.  The short-chain fatty acid octanoate 
was unable to replicate the actions of oleate on GT1-7 cells. Although oleate decreased 
GT1-7 cell mitochondrial membrane potential there was no change in total cellular ATP 
or ATP/ADP ratios. Perforated patch and whole-cell recordings from mouse 
hypothalamic slices demonstrated that oleate hyperpolarised a subpopulation of ARC GE 
neurones by KATP activation.  Additionally, in a separate small population of ARC 
neurones, oleate application or lowered glucose concentration caused membrane 
depolarisation. In conclusion, oleate induces KATP-dependent hyperpolarisation and 
inhibition of firing of a subgroup of GE hypothalamic neurones without altering cellular 
energy charge. 
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Introduction: 
The hypothalamus is critical for the continuous regulation of whole-body glucose, lipid 
and energy homeostasis. To perform this function, various hypothalamic nuclei (e.g. 
arcuate (ARC), ventromedial (VMN), lateral hypothalamic area and paraventricular) 
contain neuropeptide-expressing neurones that monitor circulating nutrients and 
hormone levels [1]. Scattered throughout these nuclei are subpopulations of neurones 
that sense changes in glucose levels, resulting in altered neuronal firing and modified 
energy homeostasis [2].  There are two main subtypes of glucose sensing hypothalamic 
neurones that contribute to these homeostatic mechanisms: neurones excited (glucose-
excited (GE)) and inhibited (glucose-inhibited (GI)) by increased levels of glucose. GE 
neurones utilise ATP-sensitive potassium (KATP) channels (in a manner similar to 
pancreatic beta cells [3]) to modulate their electrical activity in response to changes in 
extracellular glucose concentration [4-6].  It is presently unclear which ion transport 
mechanism is responsible for transducing changes in glucose concentration to modify 
electrical activity in GI neurones [7].  These glucose sensing neurones, in particular GE 
neurones, play important roles in the feeding response to glucoprivation (as 
suppression of glucokinase (GK) diminishes the glucoprivic stimulation of feeding [8]), 
and liver glucose production [9] and have been strongly implicated in the detection of 
hypoglycaemia and subsequent generation of counterregulatory responses [10]. For 
example, loss of the KATP channel subunit, KIR6.2, causes near complete suppression of 
glucagon responses to hypoglycaemia, which is driven by the loss of KATP on neural cells 
[11]. 
 Similarly, energy status (i.e. lipid level) is also communicated continuously to the 
hypothalamus. This is performed, at least in part, by hypothalamic neurones responding 
to changes in the concentrations of circulating hormones (e.g. leptin and insulin), the 
levels of which correlate with adipose tissue depot size.  It is this latter communication 
system that is considered to become faulty in obesity [12].  However, circulating lipids, 
such as long-chain fatty acids, have also been demonstrated to directly act on 
hypothalamic centres to modulate feeding and hepatic glucose output [13, 14]. 
Circulating levels can be acutely elevated, such as during fasting or hypoglycaemia, 
where lipolysis is elevated [15], therefore it is plausible that some neurons have a 
capacity to detect both reduced glucose and elevated lipid levels. Indeed the long-chain 
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fatty acid, oleate alters ARC neurone neuropeptide expression, electrical activity and 
within glucosensing neurons, can alter intracellular calcium signalling via CD36/fatty 
acid translocase [16, 17, 14, 18].  Furthermore, long-chain fatty acids are activators of 
KATP channels in pancreatic beta cells [19] and hypothalamic-delivered oleate 
suppresses hepatic glucose production in a KATP-dependent manner [14].  A previous 
study suggested that oleate alters the excitability of ARC neurones in a glucose-
concentration dependent manner suggesting interaction at the level of cellular nutrient 
metabolism [18].  In addition, the central effects of fatty acids on glucose homeostasis 
have been ascribed to neuronal fatty acid metabolism [20, 21].   
Alternatively, fatty acids can regulate the activity of mitochondrial uncoupling 
proteins (UCP) [22], including the neuronal enriched UCP isoforms, UCP4 and UCP5 [23].  
In the pancreatic beta cell, UCP2 has been implicated in regulating glucose sensing 
behaviour [24, 9, 25]. Indeed, oleate modulates the expression of UCP2 and alters 
glucose-dependent insulin secretion in pancreatic beta cells and beta cell lines [26, 27].  
Importantly, UCP2 has been shown to regulate the glucose-sensing behaviour of GE 
neurones and alter whole-body glucose homeostasis [9]. Consequently, in order to 
explore the mechanisms by which oleate modifies neuronal excitability we have 
examined the interplay between nutrient-dependent pathways and oleate responses in 
mouse GE-type neurones. 
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Methods: 
Cell Culture  
Immortalised mouse hypothalamic GnRH secreting GT1-7 cells (Pamela Mellon, San 
Diego, California, USA [13]) were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM; Sigma-Aldrich, Gillingham, UK)) with 10% fetal bovine serum (PAA 
Laboratories, Yeovil, UK & Hyclone, Pasching, Austria) as described [28]. 
 
Immunoblotting 
GT1-7 cells, seeded in 6-well dishes, were serum-starved for three hours with DMEM 
replaced by saline and then treated with nutrients (0 - 100 µM oleate or 2.5/0.1 mM 
glucose) for various times as described in the results section. We used oleate 
concentrations in the low micromolar (10-100 µM) as plasma concentrations of total 
free fatty acids have been estimated within the range of 350-500 µM under normal 
circumstances [29-31] and, in type 1 diabetes, can reach levels of more than 1200 µM 
[32].  In human CSF levels of oleate have been reported to be >10 µM in non-diabetic 
populations [33], and may be expected to reach much higher levels in type 1 diabetic 
patients. In rats, brain glucose levels have been estimated at ~2.5 and ~0.1 mM during 
euglycaemia and hypoglycaemia, respectively [34]. 
 
Protein isolation and immunoblotting procedures were as described previously [28]. 
Briefly, protein lysates were subjected to SDS-PAGE, electrotransferred to nitrocellulose 
membranes, and probed with primary antibodies against p-AMPKα (Thr172; 1:1000), p-
ACC (Ser79; 1:1000), actin (1:5000), UCP4 (1:1000) and UCP5 (1:1000). All antibodies 
were obtained from Cell Signalling Technology Inc. (New England Biolabs, Hitchin, UK) 
except UCP4 and UCP5, which were obtained from Acris Antibodies (Herford, Germany). 
Proteins were detected with horseradish peroxidase-conjugated Goat anti-Rabbit IgG 
and immunoreactive proteins identified by chemiluminescence.  Gel protein bands were 
quantified by densitometry, where total density was determined with respect to 
constant area, background subtracted and average relative band density calculated.   
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Hypothalamic Slice Preparation 
All animal procedures conformed to the UK Animals Scientific Procedures Act (1986) 
and were approved by the University of Dundee institutional ethical review committee. 
Wild-type male C57Bl/6 mice (6-20 weeks old) were killed by cervical dislocation and 
the brains rapidly removed and submerged in an ice cold slicing solution as described 
previously [35]. Briefly, hypothalamic coronal slices containing the ARC (350 µm) were 
prepared using a Vibratome (St Louis, MO, USA) and stored at room temperature (22-
25˚C) in an external solution containing (in mM): NaCl 125, KCl 2.5, NaH2PO4 1.25, 
NaHCO3 25, CaCl2 2, MgCl2 1, D-Glucose 10, D-Mannitol 15, ascorbate 1 and pyruvate 3, 
equilibrated with 95% O2, 5% CO2, pH 7.4.  Immediately before use, brain slices were 
transferred to the recording chamber of an upright Zeiss Axioskop-2 FS plus microscope 
and continuously perfused with a modified external solution (containing 0.5 mM CaCl2 
and 2.5 mM MgCl2, no ascorbate and pyruvate) at a constant flow rate of 5-10 ml min-1 
and bath temperature of 33˚C. 
 
Electrophysiology 
GT1-7 cells were visualised by phase contrast and individual neurones of mouse 
hypothalamic slices by differential interference contrast optics.  Whole-cell patch-clamp 
recordings were performed using borosilicate pipettes (4-8 MΩ) filled with an internal 
solution containing (mM): K-gluconate 130, KCl 10, EGTA 0.5, HEPES 10, NaCl 1, MgCl2 3, 
CaCl2 0.28, Na2-ATP 3, Tris-GTP 0.3, and phosphocreatine 14; pH 7.2 for ARC neurones 
and with KCl 140, EGTA 10, HEPES 10, MgCl2 5, CaCl2 3.8, and Na2-ATP 3; pH 7.2 for GT1-
7 cells. Hypothalamic neurone recordings were made in external solution at 33˚C and 
GT1-7 cell recordings at room temperature (22-25˚C) in saline containing (in mM): NaCl 
135, KCl 5, MgCl2 1, CaCl2 1, HEPES 10, glucose 2.5 (pH 7.4). For perforated patch-clamp 
recordings 30-35 µg/ml amphotericin B and/or 2.5 mg/ml gramicidin was included in 
the internal solution in the absence of Na2-ATP.  As previously described, voltage and 
current commands were manually or externally driven using pCLAMP 9.2 software and 
injected into neurones via the patch-clamp amplifier (Axopatch 200B; Molecular 
Devices, Sunnyvale CA, USA). In the whole-cell current-clamp configuration, 
hyperpolarising current pulses (5-20 pA amplitude at a frequency of 0.05 Hz) were used 
to monitor changes in input resistance. For voltage-clamp recordings the membrane 
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potential was held at -70 mV and voltage steps (20 mV increments, 200 ms duration) 
applied over the voltage range of -160 to -20 or +80 mV. Voltage-clamp protocols were 
carried out immediately after whole-cell formation, prior to and during exposure to 
drugs and/or oleate or altered glucose concentration (following achievement of maximal 
responses). At least 10 minutes of stable control data were recorded before the 
application of drugs or oleate, which were added to the external/saline solution and 
applied to slices or GT1-7 cells via a superfusion system. In some slice experiments 
oleate was applied locally via pressure ejection using a broken-tipped pipette positioned 
above the recording neurone.  
 
Nucleotide measurements 
GT1-7 cells were seeded onto black-walled 96 well plates at 1 x 104 cells per well. Total 
ATP measurements were made using ATPLite assay kit (Perkin-Elmer, Seer Green, UK), 
as per the manufacturer’s protocol, with minor modifications. Briefly, cells were lysed 
with shaking, using 40 µl of mammalian cell lysis buffer for 10 minutes at 700 rpm, 
followed by the addition of 40 µl of ATP substrate solution. For ATP/ADP ratios, cells 
were plated as for total ATP measurements. Ratios were determined using an ATP/ADP 
ratio kit (Sigma Aldrich, Gillingham, UK) as per the manufacturer’s instructions. 
 
Mitochondrial Membrane Potential  
GT1-7 cells were seeded on to glass-bottom dishes (In Vitro Scientific, CA, USA) 24 hours 
prior to study. JC-1 was used as per the manufacturer’s protocol with minor 
modifications. Briefly, cells were pre-incubated with 2µg/ml JC-1 for 1 hour at 37°C in a 
95% O2/5% CO2 humidified incubator before washing twice with saline containing 10 
mM glucose and studied immediately. Images were captured on a Leica SP5 laser 
scanning confocal microscope and fluorescence intensity analysed using the standard 
Leica LAS AF software and GraphPad Prism 5 for statistical analyses. 
 
Non-ratiometric calcium imaging 
GT1-7 cells were seeding into 96 well plates at 2x105 cells per well. Cells were loaded 
with Fluo4 Direct (ThermoFisher, UK) for 1 hour at 37 degrees. Fluorescence was 
monitored using a Pheratar FS multifunction plate reader (BMG Labtech), with oleate 
added by injection and cells maintained at 37 degrees during the imaging protocol. 
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Fluorescence is presented as relative fluorescent units (RFU), with fluorescence at the 
zero point being normalised to 1. 
Chemicals 
Amphotericin B, AMP-PNP, FA-free bovine serum albumin, diazoxide, etomoxir, 
gramicidin, malonyl-CoA, octanoic acid, oleic acid, and tolbutamide were purchased from 
Sigma-Aldrich. Compound C was obtained from Merck Chemicals Ltd (Nottingham, UK). 
Genipin was purchased from Wako Chemicals (Eastleigh, UK) and JC-1 was obtained 
from Thermo Fisher Scientific (Renfrew, UK). Oleate was prepared as a 10 mM stock 
solution containing 5% NEFA-free BSA. 
 
Statistics 
In slice recordings, hypothalamic neurones responding to drugs, oleate or altered 
glucose concentration were distinguished from non-responding neurones based on the 
criterion that the change in membrane potential (∆Vm) induced by the challenge was ± 
three times the standard deviation of the mean membrane potential prior to the 
challenge. Results are expressed as the mean ± S.E.M. of the defined responses, with the 
number of cells studied. Statistical significance was determined by Student’s t-test or 
ANOVA followed by Bonferroni’s post hoc test where appropriate. Changes in protein 
phosphorylation in Western blot experiments were analysed using a one-sample t-test 
for multiple comparisons with respect to control. A P value of less than 0.05 was 
considered statistically significant. 
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Results: 
Mouse hypothalamic GT1-7 cells exhibit GE behaviour and are oleate-sensitive 
Attempting to study the mechanism(s) by which oleate alters ARC neurone excitability is 
difficult when recording from unidentified neurones in a hypothalamic slice. Therefore, 
we utilised the mouse hypothalamic cell line, GT1-7, which exhibits GE-type properties. 
We have previously demonstrated that this neuronal cell line shows graded electrical 
responses over a physiological range of glucose concentrations and that these responses 
can be modulated by pharmacological manipulation of the classical components of 
glucose-sensing, namely glucokinase, adenosine 5’-monophosphate-activated protein 
kinase (AMPK) and KATP [36]. They therefore represent an excellent model for studying 
the mechanisms through which oleate may alter neurone excitability.  
 
In GT1-7 cells, a hypoglycaemic challenge (0.1 mM glucose) of 30 minutes resulted in 
increased AMPK phosphorylation (p-AMPK) (Fig. 1A). This was accompanied by 
increased acetyl-CoA carboxylase (ACC) phosphorylation (p-ACC), a key substrate of 
AMPK, indicating increased AMPK activity. As AMPK has been implicated as a key 
component of cellular glucose sensing in hypothalamic neurones [37], GT1-7 neurones 
[36] and pancreatic beta cells [38], we next examined whether oleate also alters AMPK 
activity. Oleate (10-100 µM; Fig. 1B) increased levels of AMPK and ACC phosphorylation 
with a minimum oleate concentration to elicit this response of > 50 µM (Fig. 1B).  Thus, 
oleate mimics the effects of lowered glucose levels on p-AMPK/p-ACC levels in GT1-7 
cells over a similar time course. Consequently, we next determined whether oleate also 
induced cell hyperpolarisation and KATP activation in GT1-7 cells as demonstrated 
previously for lowered glucose concentrations [39]. 
 
Hence we performed perforated patch recordings (which minimises disruption of 
normal cell glucose metabolism) from GT1-7 cells to monitor changes in electrical 
activity and firing frequency. Application of oleate (100 µM) to GT1-7 cells induced 
hyperpolarisation and inhibition of firing (Fig. 1C).  Baseline membrane potential was -
54.3 ± 3.1 mV, which hyperpolarised to -70.0 ± 1.5 mV following approximately 15 
minutes of oleate treatment (n = 3, P < 0.05), and reversed by application of tolbutamide 
(200µM) suggesting activation of KATP channels. The lowest concentration at which 
oleate induced a detectable hyperpolarisation of GT1-7 cells was ~50 µM (data not 
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shown).  To determine the contribution of KATP, we utilised whole-cell voltage-clamp, 
intermittent with current-clamp recordings to examine the effect of oleate on KATP 
currents following attainment of the maximal hyperpolarising response. Firstly, oleate 
hyperpolarised GT1-7 neurones (Fig. 1D upper traces) with a similar time course to that 
observed in perforated patch recordings. Secondly, this hyperpolarisation was 
accompanied by an increased total current (Fig. 1D lower traces), a shift in the reversal 
potential from –29.2 ± 6.5 mV to -58.9 ± 4.5 mV (n = 6; P < 0.01; Fig. 1E) and an 
increased slope conductance (Fig. 1F).  The increase in conductance elicited by oleate 
was returned to control levels by concomitant application of 200 µM tolbutamide (n = 3; 
Fig. 1F). Additionally, GT1-7 cells under voltage-clamp exposed to 100 µM oleate and 
subsequently challenged by addition of the direct KATP channel opener diazoxide (250 
µM) in the continued presence of oleate, demonstrated further cell hyperpolarisation 
(Fig. 1D), an additional negative shift of the reversal potential (to -76.0 ± 2.2 mV; n = 6; P 
< 0.01; Fig. 1E) with an enlarged current associated with a greater slope conductance 
(Fig. 1D, F). These actions of oleate are consistent with submaximal activation of KATP.  In 
order to assess whether the increase in AMPK activity drives the oleate-mediated 
hyperpolarisation and KATP activation, we determined the effect of oleate on whole-cell 
recordings with the AMPK inhibitor [40], compound C (20 µM) in the pipette solution. 
The presence of compound C resulted in a significantly more depolarised membrane 
potential for GT1-7 cells, in comparison to untreated control cells, but did not prevent 
oleate from hyperpolarising the cells in a tolbutamide-dependent manner (Fig. 1G). 
Consequently, these data suggest that, in contrast to lowered glucose level [35], elevated 
AMPK activity is not required for oleate-mediated activation of KATP channels and cell 
hyperpolarisation.   
 
GT1-7 cell response to OA is independent of fatty acid oxidation 
It has previously been reported that oleate induces depolarisation and excitation of 
mouse ARC proopiomelanocortin (POMC) neurones via mitochondrial β-oxidation, 
raised ATP concentration and subsequent inactivation of KATP channel activity [41].  As 
GT-7 cells respond to oleate by activation of KATP and cell hyperpolarisation such a 
mechanism was unlikely to also explain this outcome. Alternatively, increased fatty acid 
oxidation could raise reactive oxygen species levels [42-44] previously implicated in 
pathways leading to neuronal KATP activation [45].  Thus in order to examine the role of 
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fatty acid metabolism via β-oxidation we prevented the delivery of oleate to 
mitochondria by inhibition of carnitine palmitoyltransferase-1 (CPT1).  Whole-cell 
recordings were used to deliver directly to the interior of the cell (drug present in patch 
pipette solution), either malonyl-CoA (50 µM) an endogenous CPT1 inhibitor [46] or 
etoxomir (100 µM) an irreversible CPT1 inhibitor [47].  The presence of malonyl-CoA 
did not significantly alter the membrane potential of GT1-7 cells (–43.9 ± 2.3 mV; n = 10; 
P > 0.05 vs untreated controls), and subsequent challenge with oleate resulted in 
membrane potential hyperpolarisation and increased KATP conductance (Fig. 2A-C). The 
actions of oleate in the presence of malonyl-CoA were similar to that of control 
experiments (above), however, although the initial (5-10 minute) response to oleate in 
the presence of malonyl-CoA was indistinguishable from control, we did note that the 
oleate response waned with time and by 20 minutes was reduced by > 50% (Fig. 2A-C).  
This outcome could indicate a delayed reduction in fatty acid oxidation by malonyl-CoA, 
mediated perhaps by diffusion limitations. Thus, in separate experiments, we examined 
the effect of etomoxir (applied via pipette solution with a dialysis time of at least 20 
minutes prior to oleate challenge) and showed that this drug had no effect per se on the 
resting membrane potential of GT1-7 cells and did not prevent oleate from causing cell 
hyperpolarisation (Fig. 2D). Consequently, it appears unlikely that β-oxidation of oleate 
is required to elicit the inhibition of GT1-7 cell electrical activity. We next examined 
whether the short-chain fatty acid octanoate (C8), which does not require CPT1-
dependent transport into the mitochondria for oxidation, could mimic the 
hyperpolarising effect of oleate on GT1-7 cells.  Surprisingly, addition of octanoate (50 
µM) to GT1-7 cells caused a significant depolarisation, which was reversible on washout 
of the fatty acid (Fig. 2E).  However, the presence of this short-chain fatty acid did not 
prevent oleate from hyperpolarising GT1-7 cells in a tolbutamide-dependent manner 
(Fig. 2F).  These results indicate that GT1-7 cells respond by different effector 
mechanisms to short- and long-chain fatty acids. In calcium imaging studies, we found 
that oleate treatment did not alter intracellular calcium (Fig. 2H) suggesting that CD36 is 
not involved in this response. 
 
Oleate hyperpolarisation of GT1-7 cells may be dependent on ATP metabolism 
Previously it has been suggested that oleate may inhibit ATP-dependent gating of an 
acetylcholine-modulated potassium channel [48].  As KATP channel activity is controlled 
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to a large extent by the ATP/ADP ratio in cells, with ATP inhibiting and ADP activating 
KATP activity, respectively [49], a simple explanation for the oleate-mediated 
hyperpolarisation could be reduced ATP-dependent inhibition of channel activity.  To 
examine this possibility, we first decided to replace ATP with the non-hydrolysable ATP 
analogue, 5’-adenylylimidodiphosphate (AMP-PNP; 3 mM) in the pipette solution.  The 
mean GT1-7 cell resting membrane potential was significantly depolarised by the 
presence of AMP-PNP (Fig. 2G), compared to control experiments in which ATP was 
allowed to wash into the cell interior (compare with Fig. 2A).  Furthermore, neither 
oleate (up to 200 µM) nor diazoxide (250 µM) application to cells dialysed with AMP-
PNP resulted in hyperpolarisation of the membrane potential (Fig. 2G), conflicting with 
the idea that oleate may act to displace ATP from its inhibitory site on KATP. However, 
these data suggest the requirement for ATP hydrolysis for KATP activation, as previously 
demonstrated for diazoxide in beta cells [50]. 
 
Oleate reduced JC-1 mitochondrial membrane potential fluorescence without 
altering cellular energy charge 
Previous studies have indicated an important role for uncoupling protein-2 (UCP2) as a 
regulator of KATP channels in glucose-sensing neurones [9], and oleate has been 
demonstrated to increase levels of UCP2 in beta cells [26]. Increasing cellular UCP2 
levels and activity would be expected to diminish mitochondrial membrane potential 
and respiration, via uncoupling, and so reduce ATP levels, which could provide an 
explanation for oleate-mediated activation of KATP in these neurones. We examined this 
possibility by inhibiting UCP2 activity pharmacologically with genipin [51], which has 
previously been shown to reverse low glucose-mediated hyperpolarisation of pancreatic 
beta cells, GE-type hypothalamic neurones and GT1-7 cells [39, 38, 9].  In contrast we 
found that genipin was unable to reverse, or prevent, oleate from hyperpolarising GT1-7 
neurones (Fig. 3A, B) suggesting that UCP2 activity is not mediating oleate action on 
these cells.  However, on screening GT1-7 cells for additional UCP isoforms we found 
that they also express UCP4 and UCP5, although their protein levels were not altered by 
oleate treatment (Fig. 3C).  Consequently, to explore further whether uncoupling by 
oleate was a possible mechanism we assessed GT1-7 mitochondrial membrane potential 
using the membrane permeant mitochondrial dye, JC-1. Oleate significantly decreased 
JC-1 fluorescence indicating depolarisation of the mitochondrial membrane potential 
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(Fig. 3D) in a time course that mimics oleate-mediated changes in membrane potential 
and KATP current in these cells. To determine whether the oleate-induced mitochondrial 
depolarisation reduced cellular energy charge, we measured both total cellular ATP and 
the ATP/ADP ratio. Neither measure was significantly altered by exposure to increasing 
concentrations of oleate (Fig. 3E, F), further indicating that the activation of KATP 
channels by oleate is unlikely to be caused by reduced ATP-mediated inhibition.  
 
ARC neurones exhibit oleate and glucose sensitivity 
We then sought to translate our findings in GT1-7 cells to acute brain slice preparations 
from mice. First we performed perforated patch recordings on unidentified ARC 
neurones using a physiological extracellular glucose concentration (2 mM) [52, 53], 
similar to the recording conditions for the GT1-7 cells. We used hypoglycaemic challenge 
(0.1 mM glucose) and subsequent changes in membrane potential and firing rates to 
identify GE- and GI-type neurones, prior to challenge with oleate.  Thus, when GE ARC 
neurones were challenged with 0.1 mM glucose, they responded, by hyperpolarisation 
(from a Vm of –46.6 ± 1.2 mV to –53.8 ± 1.5 mV (n = 20); P < 0.01), which was reversible 
on return to 2 mM glucose solution (Fig. 4A). Subsequent addition of 100 µM oleate 
resulted in hyperpolarisation (∆Vm = –7.0 ± 1.1 mV; P < 0.01) and cessation of firing in 6 
out of 13 GE neurones tested, with concomitant application of tolbutamide (200 µM) 
reversing the hyperpolarisation caused by the presence of oleate. The remaining GE 
neurones were unaffected by oleate (data not shown). Interestingly, in ARC neurones 
that responded, reversibly, to 0.1 mM glucose by depolarisation (from a Vm of –49.3 ± 
0.8 mV to –38.9 ± 1.7 mV (n = 13; P < 0.01)) and were thus deemed GI-type, subsequent 
application of 100 µM oleate exhibited depolarisation (∆Vm = +6.4 ± 1.2 mV) in 4 out of 
7 GI neurones tested (Fig. 4B), with the remaining GI neurones unaffected (data not 
shown).  Neurones that displayed no change in membrane potential or firing rate to 0.1 
mM glucose challenge were similarly electrically unresponsive to oleate (n = 5; data not 
shown). Consequently, subpopulations of glucose sensing GE and GI ARC neurones 
respond to oleate, with the change in electrical excitability mirroring the effect of 
hypoglycaemic levels of glucose.  
 
As performed for GT1-7 cells, we also tested the effect of oleate on the electrical activity 
of mouse unidentified ARC neurones using the whole-cell current-clamp recording 
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configuration. Under these conditions the mean resting membrane potential for ARC 
neurones was –52.9 ± 0.5 mV (n = 51), similar to that reported previously for this 
recording mode in hypothalamic neurones [37, 54, 55]. Bath application or pressure 
ejection of oleate (100 µM) resulted in hyperpolarisation (Fig. 4C), with a mean ∆Vm of -
6.9 ± 0.6 mV (n = 32; P < 0.001) and inhibition of firing from 4.1 ± 0.4 Hz to 1.6 ± 0.4 Hz 
(P < 0.001). This inhibitory response was accompanied by a decrease in the mean input 
resistance from 2.13 ± 0.15 GΩ to 1.87 ± 0.16 GΩ (P < 0.05), indicative of an increased 
cell conductance.  Application of tolbutamide (200 µM) in the continued presence of 
oleate, reversed the hyperpolarisation and inhibition of firing (Fig. 4C; n = 4; P < 0.01).  
In addition, naïve ARC neurones that responded with a small depolarisation (∆Vm = +2.8 
± 1.1 mV; n = 15; P < 0.05) and increased firing to the application of 200 µM tolbutamide 
(indicating the presence of active KATP channels and so likely to be GE-type) were shown 
to be unaffected by addition of 100 µM oleate in the continued presence of tolbutamide 
(Fig. 4D). These data are in general agreement with the GT1-7 findings and indicate that 
oleate can inhibit neuronal firing by activation of KATP channels in at least a 
subpopulation of hypothalamic GE neurones. In a small number of ARC neurones under 
these whole-cell recording conditions we found that oleate caused depolarisation (∆Vm 
= +5.1 ± 0.7 mV; n = 6; P < 0.01), which resulted in no significant change in firing 
frequency (4.4 ± 1.4 Hz to 6.4 ± 0.8 Hz; n = 6; P = 0.09), possibly because the 
depolarisation was sufficient in some cases to result in inactivation of voltage-gated 
sodium/calcium channels and inhibit action potential generation (Fig. 4E).   
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Discussion 
 
Previous studies have produced disparate outcomes on whether lipid sensing 
hypothalamic neurones are also glucose sensing. Wang and colleagues [18] showed that 
there is minimal overlap between oleate sensing and glucose sensing neurones in rat 
ARC whereas Le Foll et al [16] demonstrated, using rat VMN neurones, that many GE- 
and GI-type neurones were excited and inhibited, respectively, by oleate [16, 18].  We 
find that glucose sensing ARC neurones are also oleate sensing in the same direction 
with respect to change in excitability. Thus GE neurones are inhibited by exposure to 
oleate and by lowered extracellular glucose concentration, via a KATP-dependent 
mechanism. Similarly, ARC neurones depolarised by oleate are also depolarised by 
lowered extracellular glucose concentration. These data indicate that for these mouse 
ARC neurones at least, there is a shared cellular response to increased lipid availability 
and glucose deprivation. Thus it is likely that such neurones play important roles in the 
modulation of physiological responses to the fed-fasted transition and/or in the 
pathophysiological outcomes associated with hypoglycaemia and/or starvation. Both 
insulin-induced hypoglycaemia and starvation are associated with increased lipolysis 
[15].  However, lipid levels are also elevated in the post-prandial period therefore 
perhaps the glucose level stratifies the physiological response to increased lipid 
availability. Therefore, it is possible that moderate changes lipid availability converge on 
these neurone populations to amplify an energy deficit signal or to enhance hepatic 
glucose production, depending on glucose availability. 
 
To investigate the intracellular mechanism(s) responsible for oleate sensing in 
hypothalamic GE neurones we utilised the mouse hypothalamic GnRH-releasing GT1-7 
neuronal cell line, which we have recently characterised as a GE-type glucose sensing 
neurone [39], with glucose-sensing properties similar to that described for ARC 
neurones, including POMC and AgRP neurones [37] and GnRH neurones [57].  
Challenging GT1-7s with oleate elicited hyperpolarisation and reduction or cessation of 
firing, which was reversed or prevented by tolbutamide, indicating a KATP-dependent 
mechanism, similar to that observed in ARC GE neurones under the same perforated 
patch recording conditions. As this outcome was observed on isolated GT1-7 cells, this 
suggests that the oleate response is intrinsic to neurones and cell autonomous. We have 
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previously shown that low glucose-induced opening of KATP in mouse pancreatic beta 
cells, POMC neurones and GT1-7 neurones is dependent on AMPK activity [39, 38, 37]. 
Although oleate increases AMPK activity in GT1-7 cells (similar to that observed for low 
glucose stimulation), the oleate-induced hyperpolarisation of GT1-7 cells was not 
prevented by the presence of the AMPK inhibitor, compound C. Thus oleate-driven 
modulation of KATP channel activity in GT1-7 neurones is likely mediated by a 
mechanism distinct from that of hypoglycaemia.   
 
Interestingly, the oleate-induced neuronal hyperpolarisation reported here is in contrast 
to a previous study, which demonstrated that oleate depolarised mouse ARC POMC 
neurones, which are GE-type neurones [54], by inhibition of KATP channels, an outcome 
ascribed to increased mitochondrial beta-oxidation of oleate and raised cellular ATP 
levels [41]. An alternative mechanism by which mitochondrial oxidation of oleate could 
increase KATP activity and cause cell hyperpolarisation is via the enhanced production of 
reactive oxygen species [42, 43, 19]. Importantly, the effects of oleate on energy and 
glucose homeostasis have been shown to be dependent on hypothalamic CPT1 activity 
[21, 58], indicative of fatty acid oxidation regulating hypothalamic neurones. CPT1 is 
endogenously inhibited by malonyl-CoA, the product of the reaction carried out by 
acetyl CoA carboxylase. However, we found that oleate-induced GT1-7 neurone 
hyperpolarisation was not altered by direct intracellular application of malonyl-CoA or 
by etomoxir, a pharmacological inhibitor of CPT1, suggesting that oleate-induced KATP 
channel activation and subsequent hyperpolarisation does not require mitochondrial 
fatty acid metabolism. Furthermore, the short-chain fatty acid, octanoic acid induced a 
significant depolarisation of GT1-7 cells, but did not block the hyperpolarising action of 
oleate. Moreover, oleate did not alter intracellular calcium in the GT1-7 cells, suggesting 
that the oleate-induced changes are unlikely to be mediated by CD36 driven store 
calcium release [16] or conventional PKCs . Consequently, there is no evidence to 
indicate that an alteration in fatty acid beta-oxidation or fatty acid transport via CD36 
are involved in the oleate-mediated hyperpolarisation of hypothalamic neurones. 
Perhaps this is unsurprising as mitochondrial FA metabolism predominantly generates 
ATP, which would be expected to maintain KATP channel closure, as described previously 
[41].   
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It has recently been suggested that coupling of the extracellular glucose concentration to 
KATP in pancreatic β-cells and GT1-7 neurones may also be dependent on the expression 
and activity of UCP2 [36, 38].  UCP2 acts to dissipate the proton gradient across the 
mitochondrial membrane and is expressed throughout the VMH [9] and in GT1-7 cells 
[36]. Furthermore, UCP2 is activated by long-chain fatty acids [59], including oleate [24, 
60] or indirectly via fatty acid-induced production of reactive oxygen species such  as 
superoxide [61] or lipid peroxidation intermediates [62, 63]. Thus oleate activation of 
UCP2 is expected to decrease the mitochondrial membrane potential and mitochondrial 
respiration, resulting in reduction of cellular ATP levels. Acute pharmacological 
inhibition of UCP2 with genipin did not prevent nor reverse the oleate-induced 
hyperpolarisation of GT1-7 neurones, indicating that UCP2 does not play a role in oleate-
induced changes in membrane potential. Nonetheless, indirect measurement of the 
mitochondrial membrane potential indicated that oleate induced a mild uncoupling of 
the mitochondrial membrane potential in a time course that correlated with the 
activation of KATP.  This led us to screen GT1-7 neurones for other UCP isoforms, with 
UCP4 and UCP5, the brain-enriched isoforms [64, 65], which display proton transport 
capacity within lipid membranes [23]. Both UCP4 and UCP5 were detected by 
immunoblotting, although their expression was not significantly modified over the time 
course of the oleate treatment. Importantly however, the reduced JC-1 fluorescence 
caused by oleate did not translate to a reduction in either total ATP levels or a change in 
the ATP/ADP ratio.  Therefore it is possible that oleate quenched the JC-1 fluorescence 
in a non-specific manner [66, 67] and that none of the UCP isoforms are involved in 
oleate-induced KATP channel opening. 
 
This leaves open the question of what intracellular mechanism(s) mediates oleate-
induced KATP channel activation and hyperpolarisation of GT1-7 and ARC GE neurones. 
Since ATP levels are not altered and oleate hyperpolarises GE neurones and GT1-7 cells 
(where ATP levels are clamped to maintain KATP channels closed), it is unlikely that 
activation is mediated by a deficit in ATP availability. It is possible that oleate may 
reduce ATP availability in the microdomain around the KATP channel that is not 
detectable with whole-cell ATP measurements, or that oleate (or a metabolite) alters 
KATP ATP sensitivity or displaces ATP from the nucleotide binding domain of the channel. 
An alternative possibility is that oleate is converted to a long-chain fatty acyl CoA (LC-
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CoA) in neurones. This process requires ATP hydrolysis and LC-CoA molecules have 
been demonstrated to activate KATP by binding to a specific site on the channel [68, 19]. 
 
There are a number of limitations to our studies. Firstly, we have not been able to 
address the mechanism of oleate-induced depolarisation in GI ARC neurones, in large 
part due to the lack of a suitable cell culture model. Therefore, the current that underlies 
hypoglycaemic and oleate induced neuronal depolarisation remains elusive. A recent 
mouse model developed by Stanley and colleagues [69] allowing identification of GI 
neurones for slice electrophysiology may be useful for identifying this current.   
 
The concentration of oleate used here is larger than that previously used in some studies 
of hypothalamic glucose sensing neurones [16, 18], although a recent study in humans 
measured an oleate level of > 10 µM in the CSF of non-obese humans [33]. Furthermore, 
our data demonstrating phosphorylation (inhibition) of ACC in response to 100 µM 
oleate corresponds with that previously shown to inhibit ACC and fatty acid synthesis in 
astrocytes [70]. Therefore the concentration used here probably lies in the upper end of 
the physiological level or in the pathophysiological range seen in type 1 diabetes [32] 
and/or obesity.  However, there may be a number of reasons for the discrepancies in 
oleate sensitivity. Previous studies have utilised acutely dissociated VMH neurones, the 
preparation of which may induce a stress response sufficient to alter the sensitivity of 
these neurones to alternate fuel sources. Secondly, we have used whole-cell and 
perforated patch-clamp studies to measure whole cell macroscopic currents, membrane 
potential and firing frequency whereas other studies have utilised Ca2+ imaging. Indeed, 
oleate can induce changes in intracellular calcium by mobilising [Ca2+]i stores [71], 
which may change independently of cellular membrane potential, although we did not 
observed in the current study. 
 
The ability of oleate to reproduce the effects of low glucose on glucose sensing neurones 
in the hypothalamus might be expected to drive food intake and increase hepatic glucose 
production since direct pharmacological opening of hypothalamic KATP channels drives 
glucagon and adrenaline release in the periphery during hypoglycaemia [72]. However, 
central oleate (under normoglycaemic conditions) has been shown to inhibit feeding and 
suppress glucose production, [73, 14]. This is further complicated by the observation 
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that the effect of oleate on feeding and glucose production requires the activity of KATP 
[14], indicating that the action of oleate on feeding and glucose production may utilise a 
similar intracellular mechanism described here. To examine this relation in more detail, 
it would be interesting in future experiments to examine changes in ARC neuropeptide 
ratios (NPY/POMC and AgRP/POMC) and counterregulatory hormone responses to 
insulin-induced hypoglycaemia under conditions of high (oleate infusion) or low 
(acipimox-treated) plasma fatty acid levels. It is plausible that separate subpopulations 
of ARC neurones, which are involved in discrete physiological functions [74, 75] respond 
differentially to oleate (by depolarisation, hyperpolarisation or no response).  Further 
analysis of electrophysiological responses of identified ARC neurones to oleate and other 
common dietary fatty acids, in conjunction with mouse metabolic phenotypic analysis is 
required to resolve this issue. Moreover, our studies did not examine the influence of 
hormones on low glucose and oleate responses. It is plausible that leptin, insulin and 
ghrelin, for example, modulate oleate and glucose responses, depending on the 
physiological context of energy surfeit or deficit. 
 
In summary, we have demonstrated that the long-chain unsaturated fatty acid, oleate 
alters the activity of glucose sensing hypothalamic neurones in a manner similar to that 
of a hypoglycaemic stimulus. Furthermore, by utilising a hypothalamic glucose sensing 
cell line, we show that oleate-induced KATP channel activation occurs independently of 
changes in energy charge and may involve an oleate metabolite that directly alters KATP 
channel activity. The assimilation of fatty acid and glucose sensing neuronal populations, 
along with the influence of hormones such as insulin and leptin are likely to be 
important drivers of an integrated physiological response to changing nutrient 
availability. Clearly, additional research is required to delineate the network integration 
of glucose and fatty acid sensing neurones within the hypothalamus and their relation to 
energy homeostasis. 
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Figure Legends 
Figure 1. Oleate activates AMPK and KATP in glucose sensing GT1-7 neurones 
(A) Representative immunoblots showing the effect of lowering glucose concentration 
from 2.0 to 0.1 mM on p-AMPK and p-ACC levels with time. Bar graphs show relative 
mean levels of p-AMPK and p-ACC as a function of time after challenge with 0.1 mM 
glucose (n = 6). (B) Representative immunoblots showing the effect of increasing 
concentration of oleate (10, 50 and 100 µM) on the levels of p-AMPK and p-ACC. Bar 
graphs show relative mean levels of p-AMPK and p-ACC as a function of oleate 
concentration (n = 5-8). (C) Oleate hyperpolarises GT1-7 cells within 5-15 minutes of 
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application, an action reversed on application of tolbutamide. Bar graph shows mean 
values for membrane potential of cells exposed to oleate (n = 3). (D) Whole-cell 
recording under current-clamp and switched to voltage-clamp for short periods as 
denoted by () showing that the oleate (100 µM) hyperpolarisation is sustained but 
submaximal with addition of diazoxide (250 µM) causing further hyperpolarisation 
(upper traces). The families of currents shown are from a holding potential of -70 mV 
with tests pulses between -160 and -20 mV and obtained at times marked () during the 
experiment shown in upper traces. (E) Current-voltage relationships formed with 
current amplitude values from the cell shown in (D). (F) Bar graph denotes mean slope 
conductance values (derived from best fit to current-voltage curves over -160 to -20 mV 
range) in control and after addition of 100 µM oleate, oleate + tolbutamide and oleate + 
Dzx (n = 6). (G) Effect of oleate (100 µM) on the membrane potential of a GT1-7 cell in 
which compound C (20 µM) was present in the electrode solution and allowed to dialyse 
into the cell for 20 minutes prior to oleate application.  Note that oleate hyperpolarised 
the cell, which was reversed by the addition of tolbutamide (200 µM). Bar graph shows 
mean values for membrane potential of cells dialysed with compound C ~ 2 minutes 
after formation of whole-cell configuration and after 20 minutes dialysis, followed by the 
addition of oleate, tolbutamide and extensive wash (n = 4-7).  Values are means ± SEM. 
*p<0.05, ** p<0.01, *** p<0.001 
 
Figure 2.  KATP activation by oleate is independent of AMPK, fatty acid oxidation and not 
mimicked by octanoic acid 
(A) Effect of oleate (100 µM) on membrane potential of a GT1-7 cell in which malonyl-
CoA (50 µM) was present in the electrode solution and allowed to dialyse into the cell for 
20 minutes prior to oleate application. (B) Families of currents shown are from a holding 
potential of -70 mV with tests pulses between -160 and -20 mV and obtained at the 
marked times () during the experiment shown in (A). (C) Bar graph denotes mean 
slope conductance values (derived from best fit to current-voltage curves over -160 to -
20 mV range) in control and in the presence of 100 µM oleate (n = 4), 10 and 20 minutes 
after oleate addition. (D) Effect of oleate (100 µM) on membrane potential of a GT1-7 
cell in which etomoxir (100 µM) was present in the electrode solution and allowed to 
dialyse into the cell for 20 minutes prior to oleate application. Bar graph shows mean 
values for membrane potential of untreated (concurrently performed) cells (Cont), 
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etomoxir (Etom) and Etom + oleate (n = 4). (E) Octanoic acid (50 µM) reversibly 
depolarises GT1-7 cell membrane potential. Bar graph shows mean values for 
membrane potential of cells exposed to control (Cont), octanoic acid (OctA) and 
following extensive washout of OctA (n = 8). (F) Oleate (100 µM) hyperpolarises GT1-7 
cells in the presence of OctA (50 µM), an action reversed by tolbutamide (200 µM). Bar 
graph shows mean values for membrane potential of cells exposed to control (Cont), 
octanoic acid (OctA), OctA + oleate and OctA + oleate + Tolb (n = 3-4). (G) The presence 
of AMP-PNP (3 mM) in the electrode solution (and thus dialysed into cell) resulted in cell 
depolarisation and prevented hyperpolarisation by oleate (100 µM) and DZX (250 µM). 
Bar graph shows mean values for membrane potential of cells exposed to control (Cont: 
~2 minutes after formation of whole-cell configuration and after 20 minutes dialysis, 
followed by the addition of oleate and oleate + DZX (n = 4).  (H). Calcium imaging traces 
following addition of BSA (control) of oleate (100 µM; n = 5). Values are means ± SEM. 
*p<0.05, *** p<0.001 
 
 
Figure 3. Oleate hyperpolarises GT1-7 neurones independent of UCP2 activity but 
depolarises the mitochondrial membrane potential 
(A) Representative perforated patch recording from a GT1-7 neurone showing that 100 
µM oleate-induced hyperpolarisation is unaffected by the presence of 100 µM genipin, 
and depolarised by subsequent application of 200 µM tolbutamide. Bar graph shows 
mean values for membrane potential of cells before and after application of oleate, 
followed by oleate + genipin and oleate + tolbutamide (n = 4). (B) Bar graph showing 
data from similar experiment to (A), but with 100 µM genipin added prior to challenge 
with oleate + genipin, followed by oleate + tolbutamide (n = 3). (C) Representative 
immunoblots showing the levels of UCP5, UCP4, p-ACC, p-AMPK and actin for control, 
vehicle (BSA) and oleate-treated cells. (D) Confocal images of GT1-7 cells pre-incubated 
with JC-1 under control conditions and treated with oleate (100 µM) for 20 minutes. 
Conventional light images of cells are shown on the right panels. Graph showing the 
change in JC-1 fluorescence intensity with time (relative to starting point of recording) 
for control (filled squares) and oleate-treated cells (n = 8). (E) GT1-7 total cellular ATP 
levels and (F) ATP:ADP ratios are unchanged by the addition of oleate (10, 50 and 
100µM). Values are means ± SEM. *p<0.05, *** p<0.001 
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Figure 4. Subpopulations of mouse ARC neurones respond electrically to oleate. 
(A) Representative perforated patch recording from a GE neurone, as demonstrated by 
the reversible hyperpolarisation elicited on switch from 2 mM to 0.1 mM glucose. 
Subsequent application of oleate (100 µM) in the presence of 2 mM glucose 
hyperpolarises this GE neurone. Addition of tolbutamide (200 µM) in the presence of 
oleate depolarises the neurone. Note the loss of action potentials in the presence of 
oleate + TOLB. Bar graph shows mean values (n = 6) for membrane potential of 
neurones exposed to 2.0 mM and 0.1 mM glucose and 2 mM glucose + oleate. (B) 
Representative perforated patch recording from a GI neurone, as demonstrated by the 
reversible depolarisation elicited on switch from 2 mM to 0.1 mM glucose. Subsequent 
application of oleate (100 µM) in the presence of 2 mM glucose depolarises this GI 
neurone. Bar graph shows mean values (n = 4) for membrane potential of neurones 
exposed to 2.0 mM and 0.1 mM glucose and 2.0 mM glucose + oleate. (C) Representative 
whole-cell current-clamp recording from an unidentified ARC neurone, with application 
of 100 µM oleate producing hyperpolarisation of the membrane potential and inhibition 
of firing, actions reversed by concomitant addition of tolbutamide (200 µM). Bar graph 
shows mean values (n = 4) for membrane potential of neurones exposed to: Control 
(Cont), 100 µM oleate and tolbutamide (TOLB). (D) Tolbutamide (200 µM) induced 
depolarisation and increased firing in an unidentified ARC neurone (indicating the 
presence of active KATP channels) under whole-cell current-clamp. Subsequent addition 
of oleate (100 µM) had no effect on membrane potential or firing rate. Bar graph shows 
mean values (n = 15) for membrane potential of neurones exposed to: Cont, TOLB and 
oleate + TOLB. (E) Representative whole-cell current-clamp recording from an 
unidentified ARC neurone demonstrating the addition of oleate (100 µM) depolarised 
some neurones with an overall decrease in firing and truncation of action potential 
amplitude. Bar graph shows mean values (n = 13) for membrane potential of neurones 
in Cont and exposed to oleate.  Values are means ± SEM. *p<0.05, ** p<0.01, *** p<0.001 
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Highlights 
 
• Oleate and low glucose hyperpolarise and inhibit GT1-7 and mouse GE neurones 
by activation of KATP 
• Oleate inhibition of GT1-7 neurone activity is not mediated by AMPK or fatty acid 
oxidation 
• Activation of KATP by oleate requires ATP hydrolysis but does not reduce the 
levels ATP or the ATP:ADP ratio 
• GT1-7 hyperpolarisation by oleate is not dependent on UCP2 
• Oleate and low glucose depolarise a subpopulation of hypothalamic GI neurones 
 
